CN1067555C - Application of medicinal combination containing termite population and main nest bacterial nursery - Google Patents
Application of medicinal combination containing termite population and main nest bacterial nursery Download PDFInfo
- Publication number
- CN1067555C CN1067555C CN95107728A CN95107728A CN1067555C CN 1067555 C CN1067555 C CN 1067555C CN 95107728 A CN95107728 A CN 95107728A CN 95107728 A CN95107728 A CN 95107728A CN 1067555 C CN1067555 C CN 1067555C
- Authority
- CN
- China
- Prior art keywords
- termite
- fungus
- pharmaceutical composition
- dry body
- comb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000256602 Isoptera Species 0.000 title claims abstract description 113
- 230000001580 bacterial effect Effects 0.000 title description 6
- 241000233866 Fungi Species 0.000 claims abstract description 65
- 239000003814 drug Substances 0.000 claims abstract description 45
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 44
- 208000000509 infertility Diseases 0.000 claims abstract description 12
- 230000036512 infertility Effects 0.000 claims abstract description 12
- 231100000535 infertility Toxicity 0.000 claims abstract description 12
- 241000124008 Mammalia Species 0.000 claims abstract description 8
- 206010003246 arthritis Diseases 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 9
- 241000287828 Gallus gallus Species 0.000 claims description 7
- 241000866536 Odontotermes formosanus Species 0.000 claims description 7
- 206010011224 Cough Diseases 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 5
- 206010019799 Hepatitis viral Diseases 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 201000001862 viral hepatitis Diseases 0.000 claims description 2
- 241001509962 Coptotermes formosanus Species 0.000 claims 10
- 238000005202 decontamination Methods 0.000 claims 5
- 230000003588 decontaminative effect Effects 0.000 claims 5
- 238000010298 pulverizing process Methods 0.000 claims 5
- 206010061218 Inflammation Diseases 0.000 abstract description 16
- 230000006378 damage Effects 0.000 abstract description 14
- 230000000954 anitussive effect Effects 0.000 abstract description 5
- 208000006454 hepatitis Diseases 0.000 abstract description 4
- 230000036592 analgesia Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 26
- 210000004185 liver Anatomy 0.000 description 17
- 238000000034 method Methods 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 230000007812 deficiency Effects 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 239000002775 capsule Substances 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 230000004054 inflammatory process Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 210000005069 ears Anatomy 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 6
- 108010082126 Alanine transaminase Proteins 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000257303 Hymenoptera Species 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000050510 Cunninghamia lanceolata Species 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 230000009692 acute damage Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 210000003108 foot joint Anatomy 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 235000011609 Pinus massoniana Nutrition 0.000 description 2
- 241000018650 Pinus massoniana Species 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 206010039984 Senile osteoporosis Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 241000607479 Yersinia pestis Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001760 anti-analgesic effect Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229960000905 indomethacin Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000029849 luteinization Effects 0.000 description 2
- 229940040129 luteinizing hormone Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 208000005141 Otitis Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000872198 Serjania polyphylla Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241001327916 Termitomyces albuminosus Species 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 206010003883 azoospermia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000008217 follicular development Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012317 liver biopsy Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000008634 oligospermia Diseases 0.000 description 1
- 230000036616 oligospermia Effects 0.000 description 1
- 231100000528 oligospermia Toxicity 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000002863 seminiferous tubule Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000002536 stromal cell Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种包含有含白蚁种群的白蚁至巢菌圃的干燥体的药物组合物的应用,该药物组合物中白蚁与白蚁主巢菌圃的重量比为1∶15-20。该药物组合物可用于治疗哺乳动物包括人类慢性肝炎、消炎镇痛、治疗关节炎、不孕症,并具有止咳作用,还可提高其耐寒能力。本发明变害为宝,使危害森林的白蚁得以利用。The invention provides an application of a pharmaceutical composition comprising a dried body of a termite-to-nest fungus containing termite populations. In the medicine composition, the weight ratio of the termites to the termite main nest fungus is 1:15-20. The pharmaceutical composition can be used for treating mammals including human chronic hepatitis, anti-inflammation and analgesia, treating arthritis and infertility, has antitussive effect, and can also improve its cold resistance. The invention turns harm into wealth and makes use of termites that harm forests.
Description
本发明涉及一种药物组合物应用,特别是涉及一种包含白蚁种群及其主巢菌圃的药物组合物的应用。The present invention relates to the application of a pharmaceutical composition, in particular to the application of a pharmaceutical composition comprising termite populations and their main nest fungus.
众所周知,白蚁是世界公认的五大害虫之一,危害林木、堤围、土坝,甚至房屋。全世界已知白蚁达2000余种,我国约有360余种,分布在辽宁丹东以南的25省(区)、直辖市。广泛分布于我国南方诸省的黑翅土白蚁[Odontotermes formosanus(Shiraki)]危害杉木等70余种林木,是农业和水利的主要害虫。据调查表明,千亩杉木林中黑翅土白蚁巢可多达3000多个,种群数量极其丰富。人们早已知道,白蚁本身即可供食用,从白蚁巢中菌圃上长出的鸡_菌更是美味菜肴,国内、外一些人均将其食用。As we all know, termites are one of the five major pests recognized in the world, harming trees, embankments, earth dams, and even houses. There are more than 2,000 known species of termites in the world, and there are more than 360 species in my country, which are distributed in 25 provinces (districts) and municipalities directly under the Central Government in the south of Dandong, Liaoning. Odontotermes formosanus (Shiraki), which is widely distributed in the southern provinces of my country, harms more than 70 species of forest trees such as Chinese fir, and is a major pest in agriculture and water conservancy. According to investigations, there can be as many as 3,000 black-winged soil termite nests in a thousand-acre fir forest, and the population is extremely rich. People have known for a long time that the termite itself can be edible, and the chicken mushroom grown on the fungus garden in the termite nest is a delicious dish especially, and some domestic and foreign people eat it.
白蚁隶属于昆虫纲等翅目,和其他昆虫,特别是与同属世界三大社会性昆虫的蚂蚁和蜜蜂一样,含有人体所需的18种氨基酸和包括硒、锌在内的多种微量元素,是一座微型的营养宝库,用于保健和治病,有大利而无小弊。同时,白蚁营地下生活,穴居潮湿的生态环境而有巨大的生活和繁殖能力;即使白蚁死亡,在巢中也不长霉腐烂;白蚁取食各种树木的基本营养物质(汁液);与黑翅土白蚁共生的鸡_菌,既有食用价值,又有药效(含有总黄酮,有安神作用)。Termites belong to the Insecta Isoptera. Like other insects, especially ants and bees, which belong to the world's three major social insects, termites contain 18 kinds of amino acids and various trace elements including selenium and zinc needed by the human body. It is a miniature treasure trove of nutrition, which is used for health care and treatment, with great benefits and no small disadvantages. At the same time, termites live underground in a camp, living in a humid ecological environment and have great living and reproductive capabilities; even if the termites die, they will not grow mold and rot in the nest; termites eat the basic nutrients (sap) of various trees; The gallinaceous fungus symbiotic with the termites has both edible value and medicinal effect (contains total flavonoids, which has the effect of calming the nerves).
有关白蚁及其菌圃的药用价值,己在中医药中有所报道。The medicinal value of termites and their fungi have been reported in traditional Chinese medicine.
李时珍在《本草纲目》中对白蚁已有记载。对蚁卵,李时珍曰“其卵名蚳。山人掘之,有至斗石者。石人食之,故《内则》、《周官》馈食之豆有醢也”。清代赵学敏在《本草纲目拾遗》中说及蚂蚁和蚁卵“性味甘平、微毒,益气力,泽颜色(美容),催乳汁”。用于病后体力不足,产后缺乳等,9-15g炒黄,研面冲服。Li Shizhen has recorded termites in "Compendium of Materia Medica". Regarding ant eggs, Li Shizhen said, "The name of the eggs is 蚳. Mountain people dig them up, and some go to fight with stones. Stone people eat them, so the beans that are fed in "Nei Ze" and "Zhou Guan" are also fermented." In the Qing Dynasty, Zhao Xuemin said in "Compendium of Materia Medica Supplements" that ants and ant eggs are "sweet in nature and flavor, slightly poisonous, beneficial to energy, luster (beauty), and lactating". For lack of physical strength after illness, postpartum lack of milk, etc., 9-15g stir-fried yellow, grind the noodles and take it after mixing.
白蚁的优质菌圃,李时珍在《本草纲目》中亦早有记载“白蚁泥(即蚁巢),主治恶疮肿毒,用松木上者,同黄丹各炒黑,研和香渍涂之,取愈乃止”。The high-quality fungus garden of termites, Li Shizhen also recorded in "Compendium of Materia Medica" that "termite mud (i.e. ant nest) is mainly used to treat malignant sores and swollen toxins. Those who use pine wood are fried black with yellow dan, ground and fragrant. To heal is to stop."
与白蚁菌圃共生的鸡_菌,可供药用。李时珍在《本草纲目》中指出,鸡_菌“气味甘、平、无毒。主治益胃,清神,治痔”。《中国药海》也指出其性味归经“甘、平。无毒。入心、肺、脾三经,主治健脾和胃、益气清神。The gallinaceous fungus symbiotic with the termite fungus can be used for medicine. Li Shizhen pointed out in "Compendium of Materia Medica" that the gallinaceous fungus "smells sweet, flat, and non-toxic. It is mainly used to benefit the stomach, clear the mind, and treat hemorrhoids." "Chinese Medicine Sea" also pointed out that its nature and flavor belong to "sweet, flat, non-toxic. It enters the heart, lung, and spleen meridians, and it is mainly used to strengthen the spleen and stomach, replenish qi and clear the mind.
由上述可见,白蚁巢自古以来就被广泛应用于医药界,具有益气力、补虚健脾等神奇功效。It can be seen from the above that termite nests have been widely used in the medical field since ancient times, and have miraculous effects such as nourishing energy, tonifying deficiency and invigorating the spleen.
近年来,对白蚁已有了一些应用的报导。CN1090760A提出一种用纯净白蚁作为原料、以浸泡提取等工艺得到的提取物,与山楂粉混合搅拌后制成的保健药品,该药品具有提高人体机体免疫功能的作用,对某些肿瘤有治疗效果。In recent years, some applications to termites have been reported. CN1090760A proposes a health-care medicine made by using pure termites as raw materials, extracts obtained by soaking and extracting, and mixing with hawthorn powder. The medicine has the effect of improving the immune function of the human body and has a therapeutic effect on certain tumors .
在《现代应用医学》第10卷第5期(1993年)第29-30页中报导了白蚁醇提物对S180荷瘤小鼠所具有的抑瘤活性及其免疫调节作用的研究。In "Modern Applied Medicine", Vol. 10, No. 5 (1993), pages 29-30, the research on the anti-tumor activity and immunomodulatory effect of termite alcohol extract on S180 tumor-bearing mice was reported.
CN1098628A提供了以白蚁及其菌圃为原料、采用水提取和醇提取得到提取物,将提取物制成口服液或浓缩干燥后造粒,得到的产品具有滋补提神、健脾护肝、延年益寿的功效,并指出其能提高机体的免疫能力,增强记忆和机敏力等。CN1098628A provides termites and their bacterial gardens as raw materials, water extraction and alcohol extraction to obtain extracts, the extracts are made into oral liquids or granulated after concentration and drying, and the obtained products have the functions of nourishing and refreshing, strengthening the spleen and protecting the liver, and prolonging life. Efficacy, and pointed out that it can improve the body's immunity, enhance memory and alertness, etc.
虽然现有技术中已对白蚁及其菌圃的药用价值作了叙述并得以利用,但白蚁和其菌圃对于治疗疾病的作用还远没有了解清楚。Although the medical value of termite and its fungus has been described and utilized in the prior art, the effect of termite and its fungus on treating diseases is still far from clear.
另外,由于白蚁对林木有害,长期以来,人们一直致力于杀灭白蚁,而没有在引诱杀灭白蚁、破坏白蚁巢的同时,对白蚁和蚁巢资源进行有效地利用。In addition, because termites are harmful to trees, people have been devoting themselves to killing termites for a long time, but have not effectively utilized termites and ant nest resources while luring and killing termites and destroying termite nests.
本发明的目的在于有效地利用白蚁及其菌圃、变害为宝,提供含有白蚁及其菌圃药用成份的药物组合物的医疗和保健用途。The purpose of the present invention is to effectively utilize termites and their fungus gardens, turn harm into wealth, and provide medical and health care applications of pharmaceutical compositions containing termites and their fungus gardens.
为完成上述目的,本发明提供的包含有含白蚁种群的白蚁主巢菌圃的干燥体的药物组合物在制备治疗哺乳动物包括人类慢性病毒性肝炎、避免肝损伤,抗炎、消肿、治疗关节炎,以及止咳的药中的应用,以及在制备提高哺乳动物包括人类机体耐寒能力的保健药物中的应用,本发明进一步提供包含有含白蚁种群的白蚁主巢菌圃的干燥体的药物组合物在制备治疗哺乳动物包括人类不孕症的药中的应用。In order to achieve the above object, the pharmaceutical composition provided by the present invention contains the dried body of the termite main nest bacteria nursery containing termite populations in the preparation of treatment of mammals including human chronic viral hepatitis, avoiding liver damage, anti-inflammation, detumescence, treatment of joints Inflammation, and the application in the medicine of antitussive, and the application in the health-care medicine that improves mammalian body including the human body cold tolerance, the present invention further provides the pharmaceutical composition that comprises the dried body of the termite main nest bacterial nursery containing termite population Application in preparation of medicine for treating infertility in mammals including humans.
所述的包含有含白蚁种群的白蚁主巢菌圃的干燥体的药物组合物中,所述的药物中白蚁与白蚁主巢菌圃干燥体的重量比为1∶15-20。In the pharmaceutical composition containing the dried body of the termite main nest fungus containing termite populations, the weight ratio of the termites in the medicine to the dried termite main nest fungus is 1:15-20.
所述的白蚁优选是黑翅土白蚁(Odontotermesformosanus(Shiraki)),所述的白蚁主巢菌圃是鸡_菌(Termitomyces albuminosus(Berk)Heim)。The termite is preferably Odontotermes formosanus (Shiraki), and the termite main nest fungus is Termitomyces albuminosus (Berk) Heim).
所述的药物组合物可以含有或不含有其他药用或非药用成分,如可含有其他中药成分。The pharmaceutical composition may or may not contain other medicinal or non-medicinal ingredients, such as other traditional Chinese medicine ingredients.
上述包含有含白蚁种群的白蚁主巢菌圃的干燥体的药物组合物是按步骤制备的:The above-mentioned pharmaceutical composition comprising the dried body of the termite main nest fungus containing termite populations is prepared in steps:
1)切断白蚁逃逸的蚁道,使菌圃中含有白蚁,优选是使白蚁群体大部分均在菌圃中;1) cut off the ant tunnel that termites escape, make the fungus contain termites, preferably make most of the termite colonies in the fungus;
2)将菌圃挖出;2) dig out the fungus garden;
3)将上述挖出的含白蚁种群的白蚁主巢菌圃脱水烘干,如在大约80℃下烘干,然后粉碎、去杂质;3) Dehydrating and drying the above-mentioned excavated termite main nest bacteria nursery containing termite populations, such as drying at about 80° C., and then crushing and removing impurities;
4)灭菌。4) Sterilization.
由于白蚁及其菌圃的成分比较复杂,且其本身被食用并无多少害处,故本发明采用了直接将白蚁和其菌圃干燥处理的方法,避免了有效成分的丢失,并使得本发明的方法更容易实施。Because the components of termites and their fungus gardens are relatively complex, and there is not much harm to them being eaten, the present invention adopts the method of directly drying termites and their fungus gardens, avoiding the loss of active ingredients, and making the termites and their fungus gardens dry. method is easier to implement.
本发明进一步包括由上述方法制备的药物组合物以及含有所述药物组合物的制剂,如片剂、胶囊剂等。The present invention further includes the pharmaceutical composition prepared by the above method and preparations containing the pharmaceutical composition, such as tablets, capsules and the like.
通过本发明,有效地利用了白蚁资源,特别是危害我国马尾松、杉木林、橡胶林或桉树林中黑翅土白蚁及其菌巢,变害为宝。Through the present invention, termite resources are effectively utilized, especially black-winged soil termites and their fungus nests that harm my country's masson pine, Chinese fir forests, rubber forests or eucalyptus forests, turning harm into treasure.
同时,本发明提供了新的药用原料。可防止人们过多地利用对植物生长有益的蚂蚁资源,如大黑山蚂蚁作为药用原料使用,从而达到保护益虫的作用。At the same time, the invention provides new medicinal raw materials. It can prevent people from excessively utilizing ant resources beneficial to plant growth, such as the use of Daheishan ants as medicinal raw materials, thereby achieving the effect of protecting beneficial insects.
以下详细说明本发明。The present invention will be described in detail below.
本发明选用含白蚁种群的白蚁主巢菌圃,特别是含黑翅土白蚁的白蚁主巢菌圃,其广布于我国大部地区,如辽宁、广东、广西、湖南、湖北、山东、山西、江苏、浙江、江西、台湾,福建、安徽、四川、云南、陕西、西藏、河北、河南等地,在国外,如缅甸、泰国、越南等也有分布。为保证所制备的药物的质量以冬、春季为主(10月-次年4月间),首先是选择黑翅土白蚁活巢,其主巢深度在1.5-3.0m左右,在我国南方约为0.5-1米。切断白蚁逃逸的蚁道,使白蚁群体大部分均在菌圃中,挖出后,尽快将菌圃带回室内;选择主巢为黄褐色的菌圃(内含白蚁种群)用恒温烘箱,优选在80℃左右,将菌圃脱水烘干;然后,用粉碎机将烘干后的白蚁菌圃粉碎,过筛,如过80目筛,收集干粉;干粉经灭菌,如在100℃恒温灭菌60分钟,经本领域普通技术人员公知的方法,制成本发明的包含有含白蚁种群的白蚁主巢菌圃的干燥体的药物组合物。The present invention selects the termite main nest bacterial garden that contains termite population, particularly the termite main nest bacterial garden that contains black winged soil termite, and it is widely distributed in most areas of my country, such as Liaoning, Guangdong, Guangxi, Hunan, Hubei, Shandong, Shanxi , Jiangsu, Zhejiang, Jiangxi, Taiwan, Fujian, Anhui, Sichuan, Yunnan, Shaanxi, Tibet, Hebei, Henan and other places, it is also distributed abroad, such as Myanmar, Thailand, Vietnam, etc. In order to ensure the quality of the prepared medicine is mainly based on winter and spring (October-April of the next year), at first the live nest of the black-winged soil termite is selected, and the depth of its main nest is about 1.5-3.0m. 0.5-1 meter. Cut off the ant tunnel where termites escape, so that most of the termite colonies are in the fungus garden. After digging out, bring the fungus garden back to the room as soon as possible; choose a constant temperature oven with a yellow-brown main nest (containing termite populations), preferably Dehydrate and dry the fungus at about 80°C; then, use a pulverizer to crush the dried termite fungus, and sieve it, such as passing through a 80-mesh sieve, to collect the dry powder; the dry powder is sterilized, such as at a constant temperature of 100°C Bacteria for 60 minutes, through the method known to those skilled in the art, the pharmaceutical composition of the present invention comprising the dry body of the termite main nest fungus containing termite populations is prepared.
本发明包含白蚁种群及其主巢菌圃的药物组合物的药用活性通过如下加以说明。The medicinal activity of the pharmaceutical composition of the present invention comprising a termite population and its host colony is illustrated as follows.
研究表明,白蚁及其菌巢含有人体所需的18种氨基酸和包括硒、锌在内的多种微量元素及维生素E,其中白蚁含较高的蛋白质、蚁酸、草体蚁醛及胆固醇类似肾上腺素皮质激素样物质。鸡_菌则含大量总黄酮(黄酮有安神作用)。大量的动物实验证明,白蚁及其菌巢具有明显的抗炎、消肿、镇痛作用,有降低谷丙转氨酶,保护肝脏免受毒物的损伤,并促进肝细胞急性损伤后的修复功能。临床用于人体实验还表明,服用本发明的药物组合物对类风湿和风湿性关节炎、老年性骨质疏松症、失眠、便秘等疾病均有疗效,并具有健胃抗衰老和增强免疫功效等作用。Studies have shown that termites and their nests contain 18 kinds of amino acids needed by the human body, various trace elements including selenium and zinc, and vitamin E. Among them, termites contain higher protein, formic acid, formic aldehyde and cholesterol similar to adrenal glands. Corticosteroid-like substances. Chicken bacterium contains a large amount of total flavonoids (flavonoids have a calming effect). A large number of animal experiments have proved that termites and their colonies have obvious anti-inflammatory, swelling, and analgesic effects, can reduce alanine aminotransferase, protect the liver from poisonous damage, and promote the repair function of liver cells after acute injury. Clinical use in human experiments also shows that taking the pharmaceutical composition of the present invention has curative effects on rheumatoid and rheumatoid arthritis, senile osteoporosis, insomnia, constipation and other diseases, and has the effects of invigorating the stomach, anti-aging and enhancing immunity And so on.
中医对人体的“正气”十分重视。人体正气不足,就不能有效地抗御疾病的发生或消除病邪的侵犯;而正气充沛就能在疾病发展过程中克服病邪的危害而易于康复。可见,正气旺盛与否,与疾病的发生、发展及至愈后都有密切的关系。因此,凡属体质虚弱、正气不足,都需要运用调补来增强体质和抗病能力。Chinese medicine attaches great importance to the "righteousness" of the human body. Insufficient righteousness in the human body will not be able to effectively resist the occurrence of diseases or eliminate the invasion of pathogenic factors; but sufficient righteousness will overcome the harm of pathogenic factors during the development of the disease and facilitate recovery. It can be seen that whether the righteousness is strong or not is closely related to the occurrence, development and recovery of the disease. Therefore, those who are weak in constitution and lack of righteousness need to use tonification to enhance their constitution and disease resistance.
不同的病因作用于不同的体质而形成虚证,其病机性质和传变趋向,虽然异常复杂、多样,但总括起来其病机变化不外气血阴阳虚弱和心肺脾胃肝肾虚亏。其中肾和脾在致虚的病机上极为重要。脾胃为精气生化之源,若脾胃虚弱,则水谷不化,全身失养,虚损衰竭皆至。著名中医著作《医门法律》说:“饮食不则血不生,血不生则阴不足次配阳,势必五脏齐损”。Different etiologies act on different constitutions to form deficiency syndromes. Although the nature of the pathogenesis and the tendency of transmission and change are extremely complex and diverse, the changes in the pathogenesis are nothing more than weakness of qi, blood, yin and yang, and deficiency of heart, lung, spleen, stomach, liver and kidney. Among them, kidney and spleen are extremely important in the pathogenesis of deficiency. The spleen and stomach are the source of essence and qi biochemistry, if the spleen and stomach are weak, the water and food will not be transformed, the whole body will lose nourishment, and all will be exhausted. The famous Chinese medicine book "Medical Law" said: "If the diet is not good, the blood will not grow, and if the blood does not grow, the yin will not be enough to match the yang, and all the internal organs will be damaged."
对于虚证的治疗,应以“虚则补之”、“损者益之”、“劳者温之”和“形不足者,温之以气;精不足者,补之以味”为基本法则。但人体脏腑气血来源于先天,滋生给养于后天,故调补脾肾为治疗虚证的关键所在。For the treatment of deficiency syndrome, it should be based on the principles of "replenish the deficiency", "replenish the loss", "warm the laborer" and "warm the Qi for the lack of shape; law. However, the qi and blood of the human viscera come from the innate, and the nourishment comes from the day after tomorrow. Therefore, regulating the spleen and kidney is the key to treating deficiency syndrome.
本发明的包含白蚁种群及其主巢菌圃的药物组合物非常适用于虚症失眠等虚弱病症的治疗和保健。实践经验亦表明本品扶正补虚,安全有效。The pharmaceutical composition comprising the termite population and its main nest fungus of the present invention is very suitable for the treatment and health care of debilitating diseases such as deficiency and insomnia. Practical experience also shows that this product is safe and effective in strengthening the body and tonifying deficiency.
肝炎乃因为肝炎病毒感染所致,中医认为湿热病毒侵犯人体,邪必伤正,导致人体阴阳两虚,湿热蕴结于肝,则肝胆气滞,肝属木,肾属水,在五行中肝是肾之子,子病套母气,而伤肾。肝肾同源,肾为先天之本,从而表现为心烦易怒,口干舌燥,食不腹胀,肝区隐痛等。气滞日久,必成气虚,表现为气虚乏力、神疲。本发明的药物组合物具有明显的增强体质、扶正祛邪之功。正气不足,可以有效地抵抗疾病的发生,消除病邪对人体的危害而易于康复。现代医学发现,肝炎病毒侵入人体后,在肝脏内大量复制,并不断破坏肝细胞,临床主要表现为谷丙转氨酶急剧升高。大量的动物实验及临床试验证实,本发明的药物组合物具有明显降低谷丙转氨酶作用,能保护肝脏免受毒物(CCl4)的损伤,并难促进肝细胞急性损伤后的修复功能。Hepatitis is caused by hepatitis virus infection. Traditional Chinese medicine believes that damp-heat virus invades the human body, and evil will damage the righteousness, leading to deficiency of both yin and yang in the human body. Damp-heat accumulates in the liver, leading to stagnation of liver and gallbladder qi. The liver belongs to wood, and the kidney belongs to water. Among the five elements, the liver is The son of the kidney, the child's disease traps the mother's qi, which damages the kidney. The liver and kidney are of the same origin, and the kidney is the innate foundation, which manifests as upset and irritability, dry mouth, abdominal distension, dull pain in the liver area, etc. Qi stagnation for a long time will lead to Qi deficiency, manifested as Qi deficiency, fatigue, and mental fatigue. The pharmaceutical composition of the invention has the obvious functions of strengthening body constitution, strengthening health and eliminating pathogenic factors. Insufficient righteousness can effectively resist the occurrence of diseases, eliminate the harm of pathogenic factors to the human body and facilitate recovery. Modern medicine has found that after the hepatitis virus invades the human body, it replicates in large quantities in the liver and continuously destroys liver cells. The main clinical manifestation is a sharp increase in alanine aminotransferase. A large number of animal experiments and clinical experiments prove that the pharmaceutical composition of the invention has the effect of significantly reducing alanine aminotransferase, can protect the liver from poison (CCl 4 ) damage, and hardly promote the repair function of liver cells after acute injury.
类风湿性关节炎属于祖国医学“痹症”、“历节病”范畴,中医认为“痹者闭也,以气血为邪之能闭不得通行而痛也”。痹症的发生除感受风湿邪之外,身体的强弱起着重要作用。《齐生方》明确指出,“皆因体虚,腠里空疏,受风寒湿气而成痹也”。由于气虚,阳气不足,卫阳失固,风、寒、湿三邪乘虚而入,流走脉路致气血阻滞,因此,“扶正祛邪”乃是治疗痹症的基本大法。Rheumatoid arthritis belongs to the category of "arthralgia" and "calendar disease" in traditional Chinese medicine. Traditional Chinese medicine believes that "arthralgia is closed, and the energy of Qi and blood as evil can be closed and painful." The occurrence of arthralgia is not only the feeling of rheumatism evil, but also the strength of the body plays an important role. "Qi Sheng Fang" clearly pointed out that "all are due to physical weakness, sparse interstitial space, and numbness caused by wind, cold and dampness." Due to the deficiency of qi, the deficiency of yang qi, the loss of Wei yang, the three evils of wind, cold, and dampness take advantage of the emptiness and enter, and flow through the channels, causing qi and blood to block. Therefore, "strengthening the body and eliminating pathogens" is the basic method for treating arthralgia.
本发明的药物组合物在“扶正祛邪”方面的显著作用前面已述。药理实验也证实其在抗炎、消肿、镇痛方面有明显功效,对类风湿性关节炎、老年性骨质疏松症、骨周炎等均有确切疗效。The significant effect of the pharmaceutical composition of the present invention on "strengthening the body and eliminating pathogenic factors" has been described above. Pharmacological experiments have also confirmed that it has obvious effects in anti-inflammation, detumescence, and analgesia, and has definite curative effects on rheumatoid arthritis, senile osteoporosis, and periosteitis.
在生殖方面,本发明的包含白蚁种群及其主巢菌圃的药物组合物可使因衰老或不育导致睾丸和卵巢重量下降而增至正常的水平,曲细精管内间质细胞和精母细胞内DNA、RNA含量增高,促进细胞分裂,使不孕者分泌功能得到调整,改善了下丘脑-垂体-卵巢(睾丸)轴机能。使肾气虚弱、肾不藏精、化气、生髓与功能恢复,有效地治疗不孕症。In terms of reproduction, the pharmaceutical composition comprising the termite population and its main nest bacterial garden of the present invention can increase the weight of the testes and ovaries to normal levels due to aging or infertility, and the stromal cells and spermatocytes in the seminiferous tubules The content of DNA and RNA in the cells increases, promotes cell division, adjusts the secretory function of infertile patients, and improves the function of the hypothalamus-pituitary-ovary (testis) axis. Make the kidney qi weak, the kidney does not store essence, transform qi, produce marrow and restore function, and effectively treat infertility.
本发明的包含有含白蚁种群的白蚁主巢菌圃的干燥体的药物组合物具有止咳作用。The pharmaceutical composition of the present invention comprising the dried body of the termite main nest fungus containing termite populations has antitussive effect.
本发明的药物组合物可按本领域普通技术人员公知的方法制成各种不同形式的口服剂型,如直接装入胶囊制成胶囊剂,与填充剂混合后压成片剂,或制成悬液等。The pharmaceutical composition of the present invention can be made into various oral dosage forms according to methods known to those skilled in the art, such as being directly packed into capsules to make capsules, mixed with fillers and compressed into tablets, or made into suspensions. liquid etc.
本发明的包含白蚁种群及其主巢菌圃的药物组合物用于抗炎、消肿、镇痛方面的治疗使用,用量为0.5-3g/d;用于保护肝脏、降低谷丙氨酶时用量为0.5-3g/d。作为止咳药物使用时,用量为0.25-3g/d;用于治疗不孕症使用时,用量为0.5-3g/d;作为保健药使用时,用量为0.25-1g/d。The pharmaceutical composition of the present invention comprising termite population and its main nest fungus is used for the treatment of anti-inflammation, detumescence and analgesia, and the dosage is 0.5-3g/d; when it is used for protecting the liver and reducing glutamic acid The dosage is 0.5-3g/d. When used as cough medicine, the dosage is 0.25-3g/d; when used to treat infertility, the dosage is 0.5-3g/d; when used as health care medicine, the dosage is 0.25-1g/d.
动物试验表明,本发明包含白蚁种群及其主巢菌圃的药物组合物在使用上是安全的。急性毒性实验中因小鼠胃容量有限,用250mg/ml灌喂无法求得口服的LD50,其最大耐受量为37.5g/kg,相当于临床用量的200-900倍。长期毒性试验采用高于临床应用的保健剂量200倍(4g/kg)、400倍(8g/kg)、治疗剂量50倍和100倍进行12周毒性观察,其结果表明,长期服用本发明的药物组合物不损伤动物的健康状况,不影响血液学的各项指标、不影响肝、肾等脏器的功能。可见本发明的药物组合物可长期不间断服用,安全可靠。Animal tests show that the pharmaceutical composition of the present invention comprising termite population and its main nest fungus is safe in use. In the acute toxicity test, due to the limited stomach capacity of mice, the oral LD50 cannot be obtained by gavage with 250mg/ml, and the maximum tolerated dose is 37.5g/kg, which is equivalent to 200-900 times the clinical dosage. The long-term toxicity test adopts 200 times (4g/kg), 400 times (8g/kg), 50 times and 100 times of the therapeutic dosage to carry out 12 week toxicity observations higher than the health dosage of clinical application, and its result shows, takes medicine of the present invention for a long time The composition does not damage the health status of animals, does not affect various indicators of hematology, and does not affect the functions of organs such as liver and kidney. It can be seen that the pharmaceutical composition of the present invention can be taken continuously for a long time, and is safe and reliable.
近百例志愿者服用本发明的药物组合物3月-5年,验证了下述动物实验的药效,且末发现有任何毒副作用。Nearly one hundred volunteers took the pharmaceutical composition of the present invention for 3 months to 5 years, and verified the efficacy of the following animal experiments, and no toxic side effects were found.
以下通过实施例详细说明本发明,但不限制本发明。The present invention will be described in detail below through the examples, but the present invention is not limited.
实施例1Example 1
在江苏省句容县的杉木林中,选择主巢在1.5-3.0m的黑翅土白蚁活巢,切断白蚁逃逸的蚁道,使白蚁群体大部分均在菌圃中,挖出后,尽快将菌圃带回室内;选择主巢为黄褐色的菌圃(内含白蚁种群)用恒温箱、温度定在80℃左右,将菌圃脱水烘干;用粉碎机将烘干后的菌圃粉碎,过80目筛成粉,得到干粉1000克;干粉在100℃恒温灭菌60分钟,在无菌条件下,其中500克经包装后置于低温干燥的环境中保存,另外500克装入胶囊,每粒0.25g。In the Chinese fir forest in Jurong County, Jiangsu Province, the black-winged soil termite living nest with the main nest at 1.5-3.0m was selected to cut off the ant tunnel for termite escape, so that most of the termite colony was in the fungus garden. Bring the fungus garden back to the room; select the main nest to be the yellow-brown fungus garden (containing termite population) with an incubator, set the temperature at about 80°C, dehydrate and dry the fungus garden; use a pulverizer to grind the dried fungus garden Crush, sieve through 80 meshes into powder, and obtain 1000 grams of dry powder; dry powder is sterilized at 100°C for 60 minutes, under sterile conditions, 500 grams of which are packaged and stored in a low-temperature dry environment, and the other 500 grams are packed into Capsules, 0.25g per capsule.
实施例2Example 2
在广西南宁郊区的马尾松林中,选择主巢在0.5-1.0m的黑翅土白蚁活巢,重复实施例1的方法,制成的产品500克经包装后置于低温干燥的环境中保存,另外500克加入填充剂压成每片含本实施例产品0.25g的片剂。In the Pinus massoniana forest in the suburbs of Nanning, Guangxi, select the live nest of the black-winged soil termite whose main nest is 0.5-1.0m, repeat the method of embodiment 1, and place 500 grams of products made in a low-temperature and dry environment after packaging for preservation. Another 500 grams of fillers were added and compressed into tablets each containing 0.25 g of the product of this embodiment.
实施例3Example 3
在云南西双版纳地区的橡胶林中,选择主巢在0.5-1.0m的黑翅土白蚁活巢,重复实施例1的方法,制成的产品500克经包装后置于低温干燥的环境中保存,另外500克加入填充剂压成每片含本实施例产品0.25g的片剂。In the rubber forest of Xishuangbanna area, Yunnan Province, select the live nest of the black-winged soil termite whose main nest is 0.5-1.0m, repeat the method of embodiment 1, and place 500 grams of products made in a low-temperature and dry environment after packaging to preserve. Another 500 grams of fillers were added and compressed into tablets each containing 0.25 g of the product of this embodiment.
实施例4Example 4
在广东雷州半岛的桉树林中,选择主巢在0.5-1.0m的黑翅土白蚁活巢,重复实施例1的方法,制成的产品500克经包装后置于低温干燥的环境中保存,另外500克装入胶囊,每粒含本实施例产品0.25g。In the eucalyptus forest of Leizhou Peninsula, Guangdong, select the live nest of the black winged termite whose main nest is 0.5-1.0m, repeat the method of embodiment 1, and place 500 grams of products made in a low-temperature and dry environment after packaging for preservation. Another 500 grams are packed into capsules, each containing 0.25 g of the product of this embodiment.
以下实施例用于说明本发明的药物组合物所具有的作用。实施例5-8说明其抗炎镇痛作用;实验例9显示其护肝作用;实施例10显示其提高耐寒能力的作用;实施例11说明其对不孕症的治疗作用;实施例12说明本发明的药物组合物的止咳作用。其中,所述的药物组合物是指包含白蚁种群及其主巢菌圃的药物组合物。The following examples are used to illustrate the effects of the pharmaceutical composition of the present invention. Embodiment 5-8 illustrates its anti-inflammatory and analgesic effect; Experimental example 9 shows its hepatoprotective effect; Embodiment 10 shows its effect of improving cold tolerance; Embodiment 11 illustrates its therapeutic effect on infertility; Embodiment 12 illustrates Antitussive effect of the pharmaceutical composition of the present invention. Wherein, the pharmaceutical composition refers to a pharmaceutical composition comprising termite population and its main nest fungus.
下述实施例中,所用的试验动物均来源于中国医学科学院实验动物中心,药品均为市售产品。In the following examples, the experimental animals used are all from the Experimental Animal Center of the Chinese Academy of Medical Sciences, and the drugs are all commercially available products.
实施例5对大鼠甲醛性关节炎的影响The impact of embodiment 5 on rat formaldehyde arthritis
1、药物配制:将实施例1所得的干粉,加0.5%甲基纤维素充分研磨配成悬浮液置4℃冰箱备用。1. Drug preparation: The dry powder obtained in Example 1 is fully ground with 0.5% methylcellulose to form a suspension and placed in a refrigerator at 4°C for later use.
2、材料和方法:取体重为160-180克的Wistar大鼠40只(♂♀各半),分四组,即对照组和三个剂量组,1.6克/公斤/天、3.2克/公斤/天、6.4克/公斤/天,于实验第一天灌胃后一小时,周2.5%甲醛溶液0.06ml于鼠左右肢足跖中部皮下注射致炎,5小时后测左右足关节周长。第2-5天每天喂药一次,药后1小时复测足关节,求出左右足关节周长之差,以此表示肿胀程度(即炎症程度)。2. Materials and methods: Take 40 Wistar rats with a body weight of 160-180 grams (half and half for ♂♀), divide them into four groups, namely the control group and three dosage groups, 1.6 g/kg/day, 3.2 g/kg /day, 6.4 grams/kg/day, one hour after gavage on the first day of the experiment, 0.06ml of 2.5% formaldehyde solution was injected subcutaneously in the middle part of the left and right limbs of the rats to cause inflammation, and the circumference of the left and right foot joints was measured after 5 hours. Feed the medicine once a day on the 2nd to 5th day, re-measure the foot joint 1 hour after the medicine, and find out the difference between the circumference of the left and right foot joints, which indicates the degree of swelling (ie, the degree of inflammation).
3、结果:见表一表一 3. Results: See Table 1 and Table 1
4、结论:6.4g/kg/d和3.2g/kg/d组对甲醛性关节炎有明显的抗炎消肿作用。4. Conclusion: 6.4g/kg/d and 3.2g/kg/d groups have obvious anti-inflammation and detumescence effect on formaldehyde arthritis.
实施例6对大鼠耳部二甲苯所致炎症的影响The influence of embodiment 6 on the inflammation caused by xylene in rat ear
药物配制同实施例5。Medicine preparation is with embodiment 5.
1、材料和方法:Wistar大鼠40只,体重为160-180g(♂♀各半),分成4组,分别以上述配制的药物6.4g/kg/d、3.2g/kg/d、1.6g/kg/d灌胃,每天一次,连续6次。对照组喂等体积的0.5%甲基纤维素。于末次给药后1.5小时在大鼠左耳滴二甲苯0.1ml致炎,15分钟后用直径9mm的打孔器取大鼠两耳同一部位耳圆片称重,以两耳片的差值表示炎症程度。1. Materials and methods: 40 Wistar rats with a body weight of 160-180g (♂♀ in half) were divided into 4 groups, and the drugs prepared above were given 6.4g/kg/d, 3.2g/kg/d, and 1.6g respectively. /kg/d orally, once a day, 6 times in a row. The control group was fed an equal volume of 0.5% methylcellulose. 1.5 hours after the last administration, instill 0.1ml of xylene in the left ear of the rat to cause inflammation. After 15 minutes, use a puncher with a diameter of 9mm to take ear discs from the same part of the two ears of the rat and weigh them. The difference between the two ears Indicates the degree of inflammation.
2、结果:见表二表二
3、结论:6.4g/kg/d和3.2g/kg/d组对大鼠耳部二甲苯所致炎症有明显的抗炎消肿作用。3. Conclusion: 6.4g/kg/d and 3.2g/kg/d groups have obvious anti-inflammation and detumescence effects on the inflammation caused by xylene in rat ears.
实施例7对小鼠耳部二甲苯所致炎症的影响The influence of embodiment 7 on mouse ear inflammation caused by xylene
药物配制同实施例5。Medicine preparation is with embodiment 5.
1、材料和方法:昆明小鼠30只,体重18-22g,♂♀各半,分3组,分别以上述配制的药物3。2/kg/d和1.6g/kg/d灌胃,每天一次,连续5次。对照组喂等体积的0.5%甲基纤维素。于末次给药后1.5小时在大鼠左耳滴二甲苯0.05m1致炎,15分钟后用直径9mm的打孔器取小鼠两耳同一部位耳圆片称重,以两耳片的差值表示炎症程度。1. Materials and methods: 30 Kunming mice, body weight 18-22g, ♂♀ in half, divided into 3 groups, were given the above-mentioned drug 3.2/kg/d and 1.6g/kg/d orally, every day Once, 5 consecutive times. The control group was fed an equal volume of 0.5% methylcellulose. 1.5 hours after the last administration, instill 0.05m1 of xylene in the left ear of the rat to cause inflammation. After 15 minutes, use a puncher with a diameter of 9mm to take ear discs from the same part of the two ears of the mouse and weigh them. The difference between the two ears Indicates the degree of inflammation.
2、结果:见表三2. Results: See Table 3
表三
3、结论:3.2g/kg/d的本发明的药物组合物灌胃对小鼠耳部二甲苯所致炎症有明显的抗炎消肿作用。3. Conclusion: gavage of the pharmaceutical composition of the present invention at 3.2 g/kg/d has obvious anti-inflammatory and detumescent effects on the inflammation caused by xylene in the ears of mice.
实施例8 对小鼠醋酸性腹膜炎扭体反应的影响Example 8 Effects on the Writhing Response of Acetic Peritonitis in Mice
药物配制同实施例5。Medicine preparation is with embodiment 5.
1、材料与方法:昆明种小鼠40只,体重18-22g,随机分4组,每组10只,雌雄各半。每天喂药一次,共给药三次。在第三次给药后2小时腹腔注射0.6%醋酸0.2ml致痛,记录给予化学致痛剂后15分钟内小白鼠扭体反应次数。并与对照组进行统计比较,结果见表四。1. Materials and methods: 40 Kunming mice, weighing 18-22 g, were randomly divided into 4 groups, with 10 mice in each group, half male and half male. Feed the medicine once a day for three times in total. Two hours after the third administration, 0.2 ml of 0.6% acetic acid was injected intraperitoneally to induce pain, and the number of writhing reactions of the mice within 15 minutes after administration of the chemical pain-inducing agent was recorded. And compared with the control group, the results are shown in Table 4.
表四
2、结论:本发明的药物组合物2个剂量均有显著的镇痛作用。12g/kg剂量的镇痛效果和消炎痛相同。2. Conclusion: two doses of the pharmaceutical composition of the present invention have significant analgesic effects. The analgesic effect of 12g/kg dose is the same as that of indomethacin.
实施例9Example 9
药物配制同实施例5。Medicine preparation is with embodiment 5.
1、材料方法:昆明小鼠30只,♂♀兼用,分成3组,给药组、阳性和阴性对照组。给药组剂量为5g/kg/d,每天一次连续六天。在第一次给药的前一天下午及第四次给药的下午皮下注射CCl4(40μl/只)。阳性对照组同样皮下注射CCl4,但是不喂药。在试验第7天取血,按赖氏法测定谷丙转氨酶活性,并作肝脏切片检查。1. Materials and methods: 30 Kunming mice, ♂♀ combined use, were divided into 3 groups, drug administration group, positive and negative control groups. The dosage of the administration group was 5g/kg/d, once a day for six consecutive days. In the afternoon of the day before the first administration and the afternoon of the fourth administration, CCl 4 (40 μl/rat) was subcutaneously injected. The positive control group was also subcutaneously injected with CCl 4 , but no medicine was given. On the 7th day of the experiment, blood was collected, and the activity of alanine aminotransferase was determined by Rei's method, and liver biopsy was performed.
2、结果:2. Results:
(1)谷丙转氨酶测定结果见表五(1) Alanine aminotransferase assay results are shown in Table 5
表五
(2)肝脏切片观察:阳性对照的动物肝脏小叶中央区破坏严重,服药动物的肝脏逐渐修复而与阴性对照的类似。(2) Observation of liver slices: The centrilobular region of the liver of the positive control animals was severely damaged, and the livers of the drug-administered animals gradually repaired and were similar to those of the negative control.
3、结论:通过切片观察及转氨酶活性的测定,表明:本发明药物组合物有降低谷丙转氨酶活性的作用。与阳性对照组比较差异显著,而接近阴性对照的水平。有保护肝脏免受毒物(CCl4)的损伤,并促进细胞急性损伤后的修复功能。3. Conclusion: through the section observation and the mensuration of transaminase activity, show: the pharmaceutical composition of the present invention has the effect of reducing alanine aminotransferase activity. Compared with the positive control group, the difference was significant, but close to the level of the negative control group. It can protect the liver from the damage of poison (CCl 4 ), and promote the repair function of cells after acute injury.
实施例10对小鼠耐寒的影响The impact of embodiment 10 on the cold resistance of mice
1、药物配制:1. Drug preparation:
实施例2的干粉研磨过、200目筛,用0.5%甲基纤维素配成200mg/ml悬液。The dry powder of Example 2 was ground, sieved with 200 mesh, and prepared into a 200 mg/ml suspension with 0.5% methylcellulose.
2、材料与方法:2. Materials and methods:
昆明种小鼠,雄性,体重18-22g,共36只,随机平均分成三组:(1)对照组;(2)4g/kg组;(3)8g/kg组。灌服所配制的药物,每日一次,共11次。A total of 36 Kunming mice, male, weighing 18-22 g, were randomly divided into three groups: (1) control group; (2) 4 g/kg group; (3) 8 g/kg group. The prepared medicine was fed, once a day, 11 times in total.
对照组与二个实验组动物,分别放入大烧杯中,置于-25℃低温冰箱中,冷冻2小时后,取出统计各组死亡及存活动物数。Animals in the control group and the two experimental groups were put into large beakers respectively, placed in a low-temperature refrigerator at -25°C, frozen for 2 hours, and then taken out to count the number of dead and surviving animals in each group.
3、结果:见表六3. Results: See Table 6
表六
4、结论:在相同条件,各组动物存活数不同,经统计处理,实验组与对照组显示了差别,8g/kg组与对照组比较,差别非常显著(P<0.01),表明本发明的药物组合物确有增强体质的功能。4. Conclusion: under the same conditions, each group of animal survival numbers is different, and through statistical processing, the experimental group and the matched group have shown differences, and the 8g/kg group is compared with the matched group, and the difference is very significant (P<0.01), showing that the present invention The pharmaceutical composition does have the function of enhancing physical fitness.
实施例11对治疗不孕症的临床试验Embodiment 11 to the clinical trial of treatment infertility
育龄妇女20例,原发性不孕15例,继发性5例。主要不孕病因为月经失调,基础体温(BBT)曲线显示黄体期少于12天,卵泡发育差等。按1g/d服用实施例1的胶囊90天后,月经失调得以改善,BBT曲线呈双相,黄体期大于13天,卵泡发育到1.8cm以上,排卵时出现促黄体生成素(LH)峰,局部条件CM增加性状好,经2-3疗程治疗(每疗程30天,每天1g),症状改善较为满意,显效者17例,其中3例怀孕。20 cases of women of childbearing age, 15 cases of primary infertility, 5 cases of secondary infertility. The main causes of infertility are menstrual disorders, basal body temperature (BBT) curves showing that the luteal phase is less than 12 days, and poor follicular development. After taking the capsule of Example 1 at 1 g/d for 90 days, menstrual disorders were improved, the BBT curve was biphasic, the luteal phase was greater than 13 days, and the follicle developed to more than 1.8 cm, and luteinizing hormone (LH) peak occurred during ovulation, local Conditions: CM increases and the traits are good. After 2-3 courses of treatment (30 days per course, 1g per day), the symptoms improved relatively satisfactorily. 17 cases showed significant results, and 3 of them became pregnant.
男子10例均为原发性不育,少精子症3例,精液量少于1.0ml 5例;精子活力低下2例;通过服药后(1g/d,90天),10例病人都有明显效果,特别是精液量少者,3月后都能达到大于2.0ml。10 male cases were all primary infertility, 3 cases of oligospermia, 5 cases of semen volume less than 1.0ml; The effect, especially for those with low semen volume, can reach more than 2.0ml after 3 months.
实施例12止咳作用Example 12 Antitussive effect
病例1:某女,56岁,突发性刺激性咳嗽,每年持续数月,并伴有腰腿疼,各种治疗均不见效。发作后按每日2次,每次2粒服用实施例1的胶囊,第三天咳嗽好转,服了100粒后,一年来未见咳嗽复发,且腰腿疼病也治愈了。Case 1: A female, 56 years old, had a sudden irritating cough, which lasted for several months every year, accompanied by pain in the waist and legs, and various treatments were ineffective. After the attack, take 2 capsules of embodiment 1 every day 2 times, and the cough takes a turn for the better on the third day. After taking 100 capsules, there is no recurrence of cough in the past year, and the pain in the waist and legs has also been cured.
病例2:某女,39岁,无痰性干咳,每年发作,服用中药、各种抗炎西药均不见效,每年发作持续数月。不定量服用实施例1的胶囊(1-2粒/天)后,一星期见效,停药后未见复发。Case 2: A female, 39 years old, had dry cough without phlegm, which occurred every year. Taking traditional Chinese medicine and various anti-inflammatory western medicines did not work, and the attacks lasted for several months every year. After taking the capsules (1-2 capsules/day) of embodiment 1 in a variable amount, it took effect within a week, and there was no recurrence after drug withdrawal.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95107728A CN1067555C (en) | 1995-06-30 | 1995-06-30 | Application of medicinal combination containing termite population and main nest bacterial nursery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95107728A CN1067555C (en) | 1995-06-30 | 1995-06-30 | Application of medicinal combination containing termite population and main nest bacterial nursery |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1139553A CN1139553A (en) | 1997-01-08 |
CN1067555C true CN1067555C (en) | 2001-06-27 |
Family
ID=5076427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95107728A Expired - Fee Related CN1067555C (en) | 1995-06-30 | 1995-06-30 | Application of medicinal combination containing termite population and main nest bacterial nursery |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1067555C (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101274848B (en) | 2007-03-30 | 2011-03-30 | 鸿富锦精密工业(深圳)有限公司 | Preparation for monodisperse metallic titanium |
CN101200680B (en) * | 2007-10-25 | 2010-11-17 | 樊德江 | Application of termite nest fungus comb in wine |
CN101757614B (en) * | 2010-02-22 | 2012-04-04 | 苏州汇涵医用科技发展有限公司 | Hemostatic agent and preparation method thereof |
CN102138940B (en) * | 2011-03-24 | 2012-07-04 | 江苏苏南药业实业有限公司 | Preparation method of termitarium capsule |
CN102293825B (en) * | 2011-08-29 | 2013-05-29 | 江苏苏南药业实业有限公司 | Compound termitarium and preparation method thereof |
CN106109748A (en) * | 2016-06-29 | 2016-11-16 | 江苏苏南药业实业有限公司 | A kind of Chinese medicine composition containing termitarium and preparation method thereof |
CN107137488A (en) * | 2017-05-27 | 2017-09-08 | 江苏苏南药业实业有限公司 | A kind of compound termitarium particle of anti-osteoarthritis |
CN107410931A (en) * | 2017-08-11 | 2017-12-01 | 句容市森林白蚁防治研究所 | Odontotermes formosanus is preparing the application in expediting the emergence of breast milk food |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1090760A (en) * | 1993-08-23 | 1994-08-17 | 武汉市白蚁防治所 | A kind of production method of health care medicine Coptotermes formosanus Shtrari. dry powder |
CN1098628A (en) * | 1994-06-02 | 1995-02-15 | 陈远传 | Coptotermes formosanus Shtrari. and bacterium plot series preparations thereof |
-
1995
- 1995-06-30 CN CN95107728A patent/CN1067555C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1090760A (en) * | 1993-08-23 | 1994-08-17 | 武汉市白蚁防治所 | A kind of production method of health care medicine Coptotermes formosanus Shtrari. dry powder |
CN1098628A (en) * | 1994-06-02 | 1995-02-15 | 陈远传 | Coptotermes formosanus Shtrari. and bacterium plot series preparations thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1139553A (en) | 1997-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940157B (en) | Traditional Chinese medicine feed additive for improving disease resistance of grass carp | |
CN101946856B (en) | Compound Chinese medicine micro powder and fish food for fish disease control | |
CN104068279B (en) | A kind of eel feed containing Chinese medicine additive and preparation method thereof | |
CN105410346A (en) | Cultured penaeus vannamei survival rate improving traditional Chinese medicine preparation and preparation method thereof | |
CN1067555C (en) | Application of medicinal combination containing termite population and main nest bacterial nursery | |
CN1251732C (en) | Chinese medicine for treating intrapulmonic infection and SARS | |
CN103564495B (en) | Propolis and cordycepic hypha powder composition, as well as preparation and application thereof | |
CN105727236A (en) | Powder for treating red skin disease of osphronemus goramy and preparation method thereof | |
CN104256166A (en) | Functional feed for treating bovine bluetongue and preparation method thereof | |
CN113975310A (en) | A kind of traditional Chinese medicine micropowder composition and its application in chicken ecological breeding mode | |
CN108310080A (en) | Application of the Black Box Tracing anthocyanin in preparing anti-hepatic fibrosis drug or health products | |
CN105918703A (en) | Feed additive treating megalobrama amblycephala red skin diseases and preparation method thereof | |
CN109200233B (en) | Medicine for treating bacterial diseases of lumbricus and preparation method thereof | |
CN108379252B (en) | Application of gooseberry anthocyanins in the preparation of anti-hepatic fibrosis drugs or health products | |
CN112933194A (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation for preventing and treating fish ichthyophthirius multifiliis | |
CN112972551A (en) | Method for improving mating ability of male Wistar rats | |
CN107080770B (en) | Compound traditional Chinese medicine for preventing and treating fish ringworm and its preparation and use method | |
CN107625889B (en) | Plant extract spray for improving reproductive performance of cocks | |
CN104707008B (en) | A kind of composite drug and preparation method for preventing chickens respiratory disease | |
CN104706729A (en) | Traditional Chinese medicine extract with antitumor effect as well as extraction method and application thereof | |
CN104258165A (en) | Pharmaceutical preparation for preventing loach from hemorrhagic disease | |
CN104784491A (en) | Traditional Chinese medicine preparation for treating salpingitis of laying hens and preparation method thereof | |
CN108853314A (en) | The Chinese materia medica preparation and its preparation method and application for preventing and treating frog torticollis disease | |
CN110314186A (en) | A kind of Chinese medicine composition and preparation method thereof for preventing and treating aquatic livestock enteritis | |
CN111281922B (en) | Compound traditional Chinese veterinary medicine oral preparation for treating diarrhea of pigs and poultry and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FOREST PROTECT INST CHINA FORE; INST. OF BASIC ME Free format text: FORMER OWNER: FOREST PROTECT INST CHINA FORE; INST. OF BASIC MEDICINE, CHINESE ACADEMY OF MEDICAL SCIENCES; JURONG CITY FOREST TERMITE CONTROL RESEARCH INSTITUTE Effective date: 20020409 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: FOREST PROTECT INST CHINA FORE; INST. OF BASIC MED Free format text: FORMER NAME OR ADDRESS: FOREST PROTECT INST CHINA FORE; INST. OF BASIC MEDICINE, CHINESE ACADEMY OFMEDICAL SCIENCES; RESEARCH INSTITUTE OF FOREST TERMITE CONTROL, JURONG COUNTY |
|
CP01 | Change in the name or title of a patent holder |
Patentee after: Forest Protection Research Institute China Academy of Forestry Patentee after: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES Patentee after: Institute of forest termite control Patentee before: Forest Protection Research Institute China Academy of Forestry Patentee before: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES Patentee before: Research Institute of Forest Termite Control in Jurong County |
|
TR01 | Transfer of patent right |
Effective date of registration: 20020409 Patentee after: Forest Protection Research Institute China Academy of Forestry Patentee after: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES Patentee after: Xie Baoguo Patentee after: Xie Mingrong Patentee before: Forest Protection Research Institute China Academy of Forestry Patentee before: INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES Patentee before: Institute of forest termite control |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010627 |